Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ELSE vs MLAB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLAB Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–6 Matrix Metrics)

MLAB Overall Winner 6-Pillar Tally: ELSE 2 – 3 MLAB (1 Tie) Matrix Metrics: ELSE 6 – 4 MLAB

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ELSE carries a Unified Composite Score of 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin), whereas MLAB carries 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin).

  • Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. MLAB 55.4/100 HOLD), MLAB captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -8.5% operating margin) and revenue trajectory (+2.6% vs. +15.2% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ELSE vs MLAB
ELSE NASDAQ
Electro-Sensors Inc
Industrial Instruments For Measurement, Display, And Control
$7.74
+0.0% 1D
Market Cap $27.3M
TTM Revenue $10M
Forward P/E 14.7x
Beta / 30D Vol 0.28β · 2% Vol
Unified Composite Score
57.3 / 100 HOLD
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 68
RSI-14: 68.4 · SMA20: $7.71 · SMA50: $7.69
MLAB NASDAQ Head-to-Head Winner
Mesa Laboratories Inc
Industrial Instruments For Measurement, Display, And Control
$127.93
-4.11% 1D
Market Cap $749.8M
TTM Revenue $251M
Forward P/E 23.7x
Beta / 30D Vol 1.13β · 55% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 48.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.8 · SMA20: $130.92 · SMA50: $130.04

6-Pillar Scorecard Institutional Category Breakdown (ELSE 2 – 3 MLAB)

Columns: Metric · ELSE · MLAB
1. Valuation Multiples ELSE
Forward P/E 14.7x 23.7x
Trailing P/E 96.8x 115.0x
PEG Ratio 3.15x N/M
EV / Revenue 2.6x 3.0x
2. Growth & Scale MLAB
Revenue Growth (YoY) +15.2% +2.6%
Earnings Growth (YoY) -49.1% +67.0%
TTM Revenue (USD) $10M $251M
Market Cap $27.3M $749.8M
3. Profitability & Quality MLAB
Gross Margin 51.5% 64.8%
Operating Margin -8.5% 10.4%
Net Profit Margin 2.4% 2.6%
Return on Equity (ROE) 1.7% 3.6%
4. Balance Sheet & Cash Flow MLAB
Cash Generation (TTM) $667,000 $49M EBITDA
Cash Flow Margin 6.4% 19.4% EBITDA Mgn
Net Cash / Leverage $4.22 Book/Sh · 1.7% ROE $34.66 Book/Sh · 3.6% ROE
Dividend Yield None (0.00%) 0.46%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ELSE
OpEx & R&D Intensity 60.0% of Rev ($6.3M) 54.4% of Rev ($137M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ELSE (6) vs MLAB (4)
Institutional Metric ELSE MLAB Criterion Row Edge
Market Capitalization
Scale
$27.3M $749.8M Larger Scale MLAB
Trailing P/E Ratio
Valuation
96.8x 115.0x Lower Multiple ELSE
Forward P/E Ratio
Valuation
14.7x 23.7x Lower Multiple ELSE
Revenue Growth (YoY)
Growth
+15.2% +2.6% Higher Growth ELSE
Operating Margin (TTM)
Profitability
-8.5% 10.4% Higher Margin MLAB
Net Profit Margin
Profitability
2.4% 2.6% Higher Margin MLAB
Return on Equity (ROE)
Capital Efficiency
1.7% 3.6% Higher ROE MLAB
52-Week Range Position
Momentum
100% ($4–$8) 78% ($70–$144) Stronger Trend ELSE
Beta / 30D Volatility
Risk Regime
0.28β · 2% Vol 1.13β · 55% Vol Lower Realized Risk ELSE
Unified Institutional Score
Composite Signal
57.3 / 100 (HOLD) 55.4 / 100 (HOLD) Higher Composite ELSE
Trailing 12M Revenue (USD)
Operating Scale
$10M $251M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
51.5% 64.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.15x PEG · 2.6x EV/Rev N/M PEG · 3.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$667,000 ($4.22 Book/Sh · 1.7% ROE) $49M EBITDA ($34.66 Book/Sh · 3.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MLAB +0.45 pp
ELSE: +1.05% · MLAB: +1.5%
3M Horizon MLAB +4.2 pp
ELSE: +1.31% · MLAB: +5.51%
6M Horizon ELSE +61.84 pp
ELSE: +76.78% · MLAB: +14.94%
1Y Horizon ELSE +25.03 pp
ELSE: +67.9% · MLAB: +42.87%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELSE vs MLAB. Trailing 12-month operating profitability (ELSE -8.5% vs MLAB 10.4%) and valuation multiples (ELSE 14.7x vs MLAB 23.7x Forward P/E) are benchmarked directly in Pillar 4 below.

ELSE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$10M
Gross Margin51.5%
Op. Margin-8.5%
ROE / Fwd P/E1.7% · 14.7x
MLAB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$251M
Gross Margin64.8%
Op. Margin10.4%
ROE / Fwd P/E3.6% · 23.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ELSE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MLAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ELSE Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $27.3M market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment 60.0% of Rev ($6.3M)
90D Engineering Disclosures 0 Published
MLAB Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $749.8M market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 54.4% of Rev ($137M)
90D Engineering Disclosures 0 Published

Investor FAQ ELSE vs MLAB Key Questions & Quantitative Answers

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ELSE carries a Unified Composite Score of 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin), whereas MLAB carries 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin). Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. MLAB 55.4/100 HOLD), MLAB captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -8.5% operating margin) and revenue trajectory (+2.6% vs. +15.2% YoY).

MLAB leads the Growth & Scale pillar: ELSE posts +15.2% YoY revenue growth and -49.1% YoY earnings growth on $10M TTM revenue (51.5% gross margin, -8.5% operating margin), compared with MLAB at +2.6% YoY revenue growth and +67.0% YoY earnings growth on $251M TTM revenue (64.8% gross margin, 10.4% operating margin). On trailing 12-month operating scale, ELSE generates $10M in USD-normalized revenue versus $251M for MLAB. In operating R&D and SG&A reinvestment, ELSE deploys 60.0% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 54.4% of Rev ($137M) (0 disclosures) for MLAB.

ELSE screens cheaper on headline valuation multiples. ELSE trades at 14.7x Forward P/E, 96.8x Trailing P/E, 3.15x PEG, and 2.6x EV/Revenue (6.4% FCF margin), whereas MLAB trades at 23.7x Forward P/E, 115.0x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (19.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELSE (1.7% ROE) versus MLAB (3.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ELSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 2% Vol realized risk). By comparison, MLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.13β · 55% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.